Screener
Ultralife ULBI Balance Sheet Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $6.66M-39.1% | $8.89M+2.0% | $9.35M+36.3% | $9.26M+36.7% | $10.94M+63.5% | ||
| $107.16M+8.2% | $110.1M+8.5% | $105.8M+8.9% | $100.62M+16.4% | $99M+18.2% | ||
| $39.51M-2.7% | $40.12M-0.4% | $40.4M-0.2% | $40.54M+100% | $40.61M+100% | ||
| $45.37M-0.1% | $45.33M+0.4% | $45.38M+0.8% | $45.34M+20.0% | $45.41M+21.1% | ||
| $10.39M-56.4% | $10.65M-56.0% | $10.93M-55.5% | $23.41M+61.6% | $23.84M+62.8% | ||
| $216.16M-2.2% | $220.63M-1.4% | $216.91M-1.6% | $222.25M+28.9% | $220.96M+30.1% | ||
| $22.6M+50.4% | $24.06M+44.8% | $17.42M+23.0% | $14.16M+11.7% | $15.03M+55.1% | ||
| $1.75M-49.1% | $3.44M+11.1% | $4.13M+50.0% | $3.78M+89.1% | $3.44M+71.9% | ||
| $37.36M+24.9% | $43.05M+36.7% | $37.33M+27.5% | $33.7M+28.6% | $29.9M+45.3% | ||
| $42.85M-9.8% | $44.19M-12.5% | $45.53M-11.6% | $46.52M+690% | $47.51M+376% | ||
| $83.56M+1.5% | $90.89M+4.3% | $86.78M+0.6% | $84.81M+124% | $82.32M+126% | ||
| $2.11M+0.1% | $2.11M+0.1% | $2.11M+0.1% | $2.11M+0.1% | $2.11M+0.1% | ||
| -$38.25M-20.7% | -$40.79M-25.2% | -$40.34M-17.1% | -$32.92M+5.0% | -$31.7M+9.2% | ||
| $132.51M-4.3% | $129.63M-5.0% | $130M-3.0% | $137.26M+2.1% | $138.45M+3.9% | ||
| $216.16M-2.2% | $220.63M-1.4% | $216.91M-1.6% | $222.25M+28.9% | $220.96M+30.1% |
FAQ
- What are Ultralife's total assets?
- Ultralife (ULBI) holds $216.2M in total assets, down 2.2% year over year.
- How much debt does Ultralife have?
- Ultralife carries $47.5M in total debt against $132.5M of shareholders' equity, a debt-to-equity ratio of 0.36.
- How much cash does Ultralife have?
- Ultralife holds $6.7M in cash and equivalents.
- Can Ultralife cover its short-term obligations?
- Its current ratio is 2.87 — current assets exceed current liabilities.
- Where does Ultralife's balance sheet data come from?
- Every line is extracted from Ultralife's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
